Skip to main content
LYEL logo

LYEL · Lyell Immunopharma, Inc.

$12.78 -0.06 (-0.47%) At close · Jul 23
Market Cap
$298.21M
Shares
23.33M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
56/100
Short interest 5.2% of shares — P74 Days to cover 3.4 — P66 Price vs VWAP -10.7% — P28 Short-volume trend -1.6% — P45 Short interest change -7.1% — P29 Worst FTD 0.06% of shares — P68

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,223,220 1,316,562 -93,342 3.44
2026-06-15 1,316,562 1,353,275 -36,713 9.62
2026-05-29 1,353,275 1,340,406 +12,869 16.21
2026-05-15 1,340,406 1,344,189 -3,783 23.25
2026-04-30 1,344,189 1,234,370 +109,819 18.78
2026-04-15 1,234,370 1,138,296 +96,074 12.04
2026-03-31 1,138,296 940,269 +198,027 12.78
2026-03-13 940,269 815,248 +125,021 8.59
2026-02-27 815,248 592,027 +223,221 7.63
2026-02-13 592,027 521,115 +70,912 6.28
2026-01-30 521,115 407,278 +113,837 6.09
2026-01-15 407,278 240,730 +166,548 3.96
2025-12-31 240,730 164,482 +76,248 1.58
2025-12-15 164,482 161,792 +2,690 2.44
2025-11-28 161,792 163,125 -1,333 3.35
2025-11-14 163,125 166,193 -3,068 5.91
2025-10-31 166,193 183,877 -17,684 6.54
2025-10-15 183,877 233,067 -49,190 4.88
2025-09-30 233,067 162,607 +70,460 2.60
2025-09-15 162,607 145,675 +16,932 5.78
2025-08-29 145,675 132,974 +12,701 6.27
2025-08-15 132,974 188,200 -55,226 3.95
2025-07-31 188,200 243,764 -55,564 1.98
Showing 1–23 of 23 settlements
Key facts CIK 1806952 CUSIP 55083R203 13F (30d) 3 filings 3 filers Visit website Investor relations